Ask AI
ProCE Banner Activity

Could It Be MASH? Early Detection and Intervention to Improve Metabolic Outcomes

Slideset

Expert-curated slides on metabolic dysfunction–associated steatotic liver disease (MASLD) or metabolic dysfunction–associated steatohepatitis (MASH), including strategies for screening, risk stratification, and implementation of the latest treatment guidance and emerging therapies in your clinical practice.

Released: June 17, 2025

Expiration: June 16, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Novo Nordisk.

Boehringer Ingelheim Pharmaceuticals, Inc.

Novo Nordisk